Continuous Glucose Monitoring Use in Clinical Trials for On-Market Diabetes Drugs.

Fox, Bradley Q; Benjamin, Peninah F; Aqeel, Ammara; Fitts, Emily; Flynn, Spencer; Levine, Brian; Maslak, Elizaveta; Milner, Rebecca L; Ose, Benjamin; Poeschla, Michael; Ray, Meghna; Serino, Maeve; Shah, Sahaj S; Close, Kelly L

Fox, Bradley Q; Benjamin, Peninah F; Aqeel, Ammara; Fitts, Emily; Flynn, Spencer; Levine, Brian; Maslak, Elizaveta; Milner, Rebecca L; Ose, Benjamin; Poeschla, Michael; Ray, Meghna; Serino, Maeve; Shah, Sahaj S; Close, Kelly L.

Afiliação

Fox BQ; Close Concerns, San Francisco, CA.
Benjamin PF; Close Concerns, San Francisco, CA.
Aqeel A; Dartmouth College, Hanover, NH.
Fitts E; Close Concerns, San Francisco, CA.
Flynn S; Duke University, Durham, NC.
Levine B; The diaTribe Foundation, San Francisco, CA.
Maslak E; Close Concerns, San Francisco, CA.
Milner RL; Close Concerns, San Francisco, CA.
Ose B; Close Concerns, San Francisco, CA.
Poeschla M; Dartmouth College, Hanover, NH.
Ray M; Close Concerns, San Francisco, CA.
Serino M; Close Concerns, San Francisco, CA.
Shah SS; Dartmouth College, Hanover, NH.
Close KL; Close Concerns, San Francisco, CA.

Clin Diabetes ; 39(2): 160-166, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33986569

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Clin Diabetes Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google